STR Profiling Reveals Tumor Genome Instability in Primary Mediastinal B-Cell Lymphoma

Primary mediastinal B-cell lymphoma (PMBCL) is the only non-Hodgkin’s lymphoma variant responding to immune checkpoint inhibitor (ICI) therapy, approximately in half of the cases; however, no molecular markers predicting a response to ICI therapy in PMBCL have been described so far. In this study, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Risinskaya, Natalya, Mangasarova, Yana, Nikulina, Elena, Kozhevnikova, Yana, Chabaeva, Julia, Yushkova, Anna, Magomedova, Aminat, Kulikov, Sergey, Julhakyan, Hunan, Kravchenko, Sergey, Sudarikov, Andrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139229/
https://www.ncbi.nlm.nih.gov/pubmed/35621668
http://dx.doi.org/10.3390/curroncol29050278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139229/
https://www.ncbi.nlm.nih.gov/pubmed/35621668
http://dx.doi.org/10.3390/curroncol29050278

Ejemplares similares